<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01001533</url>
  </required_header>
  <id_info>
    <org_study_id>09-03-0130</org_study_id>
    <nct_id>NCT01001533</nct_id>
  </id_info>
  <brief_title>Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation</brief_title>
  <acronym>DEX-CO</acronym>
  <official_title>A Pilot Study to Assess the Ability of Non-invasive Bio-impedance Cardiac Monitoring to Detect and Trend Hemodynamic Variables During Dexmedetomidine (DEX) Sedation in Children for Radiology Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the use of a new FDA-approved non-invasive&#xD;
      bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in&#xD;
      children undergoing radiology procedures. The purpose of the study is to determine the&#xD;
      ability of the ICON monitor to identify the anticipated and documented hemodynamic changes in&#xD;
      children which occur in response to Dexmedetomidine sedation. The investigators postulate&#xD;
      that if the ICON device can trend hemodynamic changes, if any, during dexmedetomidine (DEX)&#xD;
      sedation in children the investigators can delineate changes in cardiac output, stroke&#xD;
      volume, and systemic vascular resistance associated with observed changes in heart rate and&#xD;
      blood pressure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The primary aim is to ascertain if a decrease in heart rate (HR) with intravenous (IV) DEX is associated with a change in trend of cardiac output (CO) as measured by the ICON device.</measure>
    <time_frame>pre-, during, and post sedation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine the cardiac parameters provided by the ICON device during changes in blood pressure.</measure>
    <time_frame>pre-, during and post sedation</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">17</enrollment>
  <condition>Cardiac Output</condition>
  <condition>Sedation</condition>
  <arm_group>
    <arm_group_label>Children sedated by DEX</arm_group_label>
    <description>All pediatric patients (1 month to 18 years of age) eligible for Radiology Sedation Service for CT scan and Nuclear Medicine Scan procedure.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All pediatric patients (1 month to 18 years of age) eligible for Radiology Sedation Service&#xD;
        for CT scan and Nuclear Medicine Scan procedure who agrees to participate in the study will&#xD;
        have their vital signs and ICON measurements recorded continuously pre-sedation, during&#xD;
        sedation and through recovery until discharge.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All pediatric patients (1 month to 18 years of age)&#xD;
&#xD;
          -  Eligible for Radiology Sedation Service for CT scan and Nuclear Medicine&#xD;
&#xD;
          -  Scan procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pacemakers and Vagus Nerve Stimulator&#xD;
&#xD;
          -  Mitral or Aorta Valve Dysfunction&#xD;
&#xD;
          -  Dextrocardia&#xD;
&#xD;
          -  Second or Third degree heart block&#xD;
&#xD;
          -  Current diagnosis of Cardiac, Pulmonary, Hepatic or Renal Failure&#xD;
&#xD;
          -  Current diagnosis of pulmonary masses/tumor/pleural effusions/pneumonia/edema&#xD;
&#xD;
          -  Pericardial effusion&#xD;
&#xD;
          -  Concomitant use of hypertension medications including ACE inhibitors, beta receptor&#xD;
             and calcium channel blockers.&#xD;
&#xD;
          -  Large Implanted Metallic Devices (including orthodontic braces, spine rods, plates and&#xD;
             screws)&#xD;
&#xD;
          -  Allergy to device electrodes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jackson Wong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children Hospital Boston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <study_first_submitted>October 23, 2009</study_first_submitted>
  <study_first_submitted_qc>October 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 26, 2009</study_first_posted>
  <last_update_submitted>January 4, 2017</last_update_submitted>
  <last_update_submitted_qc>January 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>Jackson Wong</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Electrical Cardiometry</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>ICON</keyword>
  <keyword>bio-impedance</keyword>
  <keyword>cardiac monitor</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

